SAHA enhances proteostasis of epilepsy-associated α1(A322D) β2γ2 GABAA Receptors

Chemistry and Biology

Volumn 20, Issue 12, 2013, Pages 1456-1468

  Di, Xiao Jing ^a   Han, Dong Yun ^a   Wang, Ya Juan ^a   Chance, Mark R ^a   Mu, Ting Wei ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA1(A322D) BETA2GAMMA2 RECEPTOR; CALNEXIN; GLUCOSE REGULATED PROTEIN 78; UNCLASSIFIED DRUG; VORINOSTAT;

ARTICLE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; EPILEPSY; FOOD AND DRUG ADMINISTRATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION; WILD TYPE;

MAMMALIA;

CALNEXIN; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; POINT MUTATION; PROTEIN FOLDING; PROTEIN INTERACTION MAPS; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RECEPTORS, GABA-A;

EID: 84890858016     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.09.020     Document Type: Article

References (58)

1. Y. Adachi, K. Yamamoto, T. Okada, H. Yoshida, A. Harada, and K. Mori ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum Cell Struct. Funct. 33 2008 75 89
2. N.N. Alder, and A.E. Johnson Cotranslational membrane protein biogenesis at the endoplasmic reticulum J. Biol. Chem. 279 2004 22787 22790
3. W.E. Balch, R.I. Morimoto, A. Dillin, and J.W. Kelly Adapting proteostasis for disease intervention Science 319 2008 916 919
4. M. Bouchecareilh, D.M. Hutt, P. Szajner, T.R. Flotte, and W.E. Balch Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency J. Biol. Chem. 287 2012 38265 38278
5. I. Braakman, and N.J. Bulleid Protein folding and modification in the mammalian endoplasmic reticulum Annu. Rev. Biochem. 80 2011 71 99
6. C.A. Bradley, C. Taghibiglou, G.L. Collingridge, and Y.T. Wang Mechanisms involved in the reduction of GABAA receptor alpha1-subunit expression caused by the epilepsy mutation A322D in the trafficking-competent receptor J. Biol. Chem. 283 2008 22043 22050
7. B. Bukau, J. Weissman, and A. Horwich Molecular chaperones and protein quality control Cell 125 2006 443 451
8. C. Choudhary, C. Kumar, F. Gnad, M.L. Nielsen, M. Rehman, T.C. Walther, J.V. Olsen, and M. Mann Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 2009 834 840
9. C.N. Connolly, B.J. Krishek, B.J. McDonald, T.G. Smart, and S.J. Moss Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors J. Biol. Chem. 271 1996 89 96
10. P. Cossette, L.D. Liu, K. Brisebois, H.H. Dong, A. Lortie, M. Vanasse, J.M. Saint-Hilaire, L. Carmant, A. Verner, and W.Y. Lu et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy Nat. Genet. 31 2002 184 189
11. E. Deuerling, and B. Bukau Chaperone-assisted folding of newly synthesized proteins in the cytosol Crit. Rev. Biochem. Mol. Biol. 39 2004 261 277
12. L. Ding, H.-J. Feng, R.L. Macdonald, E.J. Botzolakis, N. Hu, and M.J. Gallagher GABA(A) Receptor alpha 1 Subunit Mutation A322D Associated with Autosomal Dominant Juvenile Myoclonic Epilepsy Reduces the Expression and Alters the Composition of Wild Type GABA(A) Receptors. J. Biol. Chem. 285 2010 26390 26405
13. M. Dokmanovic, G. Perez, W. Xu, L. Ngo, C. Clarke, R.B. Parmigiani, and P.A. Marks Histone deacetylase inhibitors selectively suppress expression of HDAC7 Mol. Cancer Ther. 6 2007 2525 2534
14. M. Dong, J.P. Bridges, K. Apsley, Y. Xu, and T.E. Weaver ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C Mol. Biol. Cell 19 2008 2620 2630
15. D.A. Dougherty Cys-loop neuroreceptors: structure to the rescue? Chem. Rev. 108 2008 1642 1653
16. J. Dudek, J. Benedix, S. Cappel, M. Greiner, C. Jalal, L. Müller, and R. Zimmermann Functions and pathologies of BiP and its interaction partners Cell. Mol. Life Sci. 66 2009 1556 1569
17. R.S. Eshaq, L.D. Stahl, R. Stone 2nd, S.S. Smith, L.C. Robinson, and N.J. Leidenheimer GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors Brain Res. 1346 2010 1 13
18. E. Ficker, D. Thomas, P.C. Viswanathan, A.T. Dennis, S.G. Priori, C. Napolitano, M. Memmi, B.A. Wible, E.S. Kaufman, and S. Iyengar et al. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am. J. Physiol.- Heart C. 279 2000 H1748 H1756
19. G.C. Flynn, J. Pohl, M.T. Flocco, and J.E. Rothman Peptide-binding specificity of the molecular chaperone BiP Nature 353 1991 726 730
20. J. Frydman Folding of newly translated proteins in vivo: the role of molecular chaperones Annu. Rev. Biochem. 70 2001 603 647
21. M.J. Gallagher, L. Ding, A. Maheshwari, and R.L. Macdonald The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation Proc. Natl. Acad. Sci. USA 104 2007 12999 13004
22. T. Gidalevitz, V. Prahlad, and R.I. Morimoto The stress of protein misfolding: from single cells to multicellular organisms Cold Spring Harb. Perspect. Biol. 3 2011 a009704
23. K.B. Glaser, M.J. Staver, J.F. Waring, J. Stender, R.G. Ulrich, and S.K. Davidsen Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines Mol. Cancer Ther. 2 2003 151 163
24. W.N. Green, and N.S. Millar Ion-channel assembly Trends Neurosci. 18 1995 280 287
25. C.J. Guerriero, and J.L. Brodsky The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology Physiol. Rev. 92 2012 537 576
26. F.U. Hartl, and M. Hayer-Hartl Molecular chaperones in the cytosol: from nascent chain to folded protein Science 295 2002 1852 1858
27. F.U. Hartl, A. Bracher, and M. Hayer-Hartl Molecular chaperones in protein folding and proteostasis Nature 475 2011 324 332
28. D.N. Hebert, and M. Molinari In and out of the ER: protein folding, quality control, degradation, and related human diseases Physiol. Rev. 87 2007 1377 1408
29. D.N. Hebert, and M. Molinari Flagging and docking: dual roles for N-glycans in protein quality control and cellular proteostasis Trends Biochem. Sci. 37 2012 404 410
30. D.N. Hebert, J.F. Simons, J.R. Peterson, and A. Helenius Calnexin, calreticulin, and Bip/Kar2p in protein folding Cold Spring Harb. Symp. Quant. Biol. 60 1995 405 415
31. D.N. Hebert, R. Bernasconi, and M. Molinari ERAD substrates: which way out? Semin. Cell Dev. Biol. 21 2010 526 532
32. A. Helenius, and M. Aebi Roles of N-linked glycans in the endoplasmic reticulum Annu. Rev. Biochem. 73 2004 1019 1049
33. A. Helenius, E.S. Trombetta, D.N. Hebert, and J.F. Simons Calnexin, calreticulin and the folding of glycoproteins Trends Cell Biol. 7 1997 193 200
34. M. Hentschke, M. Wiemann, S. Hentschke, I. Kurth, I. Hermans-Borgmeyer, T. Seidenbecher, T.J. Jentsch, A. Gal, and C.A. Hübner Mice with a targeted disruption of the Cl-/HCO3- exchanger AE3 display a reduced seizure threshold Mol. Cell. Biol. 26 2006 182 191
35. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X.B. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, and P.A.S. Lowden et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. USA 100 2003 2041 2046
36. D.M. Hutt, D. Herman, A.P.C. Rodrigues, S. Noel, J.M. Pilewski, J. Matteson, B. Hoch, W. Kellner, J.W. Kelly, and A. Schmidt et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis Nat. Chem. Biol. 6 2010 25 33
37. W.K. Kelly, O. O'Connor, V.M. Richon, T. Curley, S. Richardson, D. Thapi, J.H. Chiao, R.A. Rifkind, P.A. Marks, and H.I. Scher Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SARA) Clin. Cancer Res. 9 2003 6245S 6246S
38. K. Krampfl, S. Maljevic, P. Cossette, E. Ziegler, G.A. Rouleau, H. Lerche, and J. Bufler Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy Eur. J. Neurosci. 22 2005 10 20
39. P. Lachance-Touchette, P. Brown, C. Meloche, P. Kinirons, L. Lapointe, H. Lacasse, A. Lortie, L. Carmant, F. Bedford, D. Bowie, and P. Cossette Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy Eur. J. Neurosci. 34 2011 237 249
40. A. Lafon, E. Petty, and L. Pillus Functional antagonism between Sas3 and Gcn5 acetyltransferases and ISWI chromatin remodelers PLoS Genet. 8 2012 e1002994
41. A.H. Lee, N.N. Iwakoshi, and L.H. Glimcher XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response Mol. Cell. Biol. 23 2003 7448 7459
42. H.A. Lester, M.I. Dibas, D.S. Dahan, J.F. Leite, and D.A. Dougherty Cys-loop receptors: new twists and turns Trends Neurosci. 27 2004 329 336
43. S. Lindquist The heat-shock response Annu. Rev. Biochem. 55 1986 1151 1191
44. W.-y. Lo, A.H. Lagrange, C.C. Hernandez, R. Harrison, A. Dell, S.M. Haslam, J.H. Sheehan, and R.L. Macdonald Glycosylation of beta 2 Subunits Regulates GABA(A) Receptor Biogenesis and Channel Gating. J. Biol. Chem. 285 2010 31348 31361
45. J. Lu, C. Yang, M. Chen, D.Y. Ye, R.R. Lonser, R.O. Brady, and Z. Zhuang Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease Proc. Natl. Acad. Sci. USA 108 2011 21200 21205
46. R.L. Macdonald, and R.W. Olsen GABAA receptor channels Annu. Rev. Neurosci. 17 1994 569 602
47. T.W. Mu, D.S.T. Ong, Y.J. Wang, W.E. Balch, J.R. Yates 3rd, L. Segatori, and J.W. Kelly Chemical and biological approaches synergize to ameliorate protein-folding diseases Cell 134 2008 769 781
48. T. Okada, H. Yoshida, R. Akazawa, M. Negishi, and K. Mori Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response Biochem. J. 366 2002 585 594
49. J.H. Otero, B. Lizák, and L.M. Hendershot Life and death of a BiP substrate Semin. Cell Dev. Biol. 21 2010 472 478
50. S. Rüdiger, L. Germeroth, J. Schneider-Mergener, and B. Bukau Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries EMBO J. 16 1997 1501 1507
51. L.A. Rutkevich, and D.B. Williams Participation of lectin chaperones and thiol oxidoreductases in protein folding within the endoplasmic reticulum Curr. Opin. Cell Biol. 23 2011 157 166
52. M. Schröder, and R.J. Kaufman The mammalian unfolded protein response Annu. Rev. Biochem. 74 2005 739 789
53. J.F. Simons, S. Ferro-Novick, M.D. Rose, and A. Helenius BiP/Kar2p serves as a molecular chaperone during carboxypeptidase Y folding in yeast J. Cell Biol. 130 1995 41 49
54. W.R. Skach Cellular mechanisms of membrane protein folding Nat. Struct. Mol. Biol. 16 2009 606 612
55. M.H. Smith, H.L. Ploegh, and J.S. Weissman Road to ruin: targeting proteins for degradation in the endoplasmic reticulum Science 334 2011 1086 1090
56. R. Ushioda, J. Hoseki, K. Araki, G. Jansen, D.Y. Thomas, and K. Nagata ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER Science 321 2008 569 572
57. S.S. Vembar, and J.L. Brodsky One step at a time: endoplasmic reticulum-associated degradation Nat. Rev. Mol. Cell Biol. 9 2008 944 957
58. P. Walter, and D. Ron The unfolded protein response: from stress pathway to homeostatic regulation Science 334 2011 1081 1086